Campbell Soup has sold its Habit personalised nutrition business to healthcare company Viome.
Habit was founded in 2015 with a mission to transform human health through its proprietary testing methodologies and personal nutrition guidance. Campbell Soup has been the business’s sole strategic investor and majority shareholder since its inception.
Viome said the acquisition will allow it to expand its core offering by tapping into Habit’s “robust insights for consumer behaviour modification”. With this, both companies aim to provide a richer consumer experience and deepen personalised recommendations with nutrition plans and engagement tools.
US-based Viome uses artificial intelligence to understand what is going on inside the body at a molecular level. It targets the bacteria, viruses, yeast, fungus and mould in the system that work symbiotically with the body to provide the nutrition needed to feel energetic and stay healthy.
“With Habit now part of Viome, we have the perfect articulation of personalised health,” said Viome founder and CEO Naveen Jain.
“I have always admired Habit’s ability to engage and motivate the consumer. Combined with Viome’s deep insights from the microbiome, we are able to see the complete story our body is telling us about our overall health.”
Habit founder and CEO Neil Grimmer added: “With the advent of big data and computational biology, I believe it’s possible to provide everyone in this country and around the world a personalised blueprint to achieve their health and wellness goals.
“Viome analyses the gut microbiome at a molecular level with advanced technology from the Los Alamos National Lab, which is a great competitive advantage and great foundation for creating the ultimate whole-body nutrition solution.”
Source: FoodBev
Campbell Soup has completed the acquisition of Sovos Brands for $23 per share in an all-cash transaction. The deal represents a total enterprise value of approximately $2.7 billion. As previously reported by FoodBev, the two companies announced the acquisition in August 2022.
Chocolate manufacturers have raised prices for consumers due to three consecutive years of low cocoa harvests in the two countries responsible for nearly 60% of the world’s cocoa production, with a fourth poor harvest anticipated, causing cocoa prices to more than double over the past year.
The hub, which will focus on producing sweet proteins via precision fermentation, is part of a deal signed between Novel Foods, Glatt Group, BioEngineering and CB Consultancy during the inaugural Healthy Innovation Conference held recently in Dubai.